Emergency contraception and risk of ectopic pregnancy: Is there need for extra vigilance? [1]

Annals of Emergency Medicine

Volumn 42, Issue 2, 2003, Pages 306-307

  Vinson, David R ^a  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVONELLE; LEVONORGESTREL; NORGESTREL; NORVELO;

CLINICAL FEATURE; CLINICAL TRIAL; CONTRACEPTION; ECTOPIC PREGNANCY; EMERGENCY TREATMENT; FEMALE; HUMAN; LETTER; PRIORITY JOURNAL; RISK; TREATMENT FAILURE; TREATMENT INDICATION; VALIDATION PROCESS;

EID: 0041846683     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1067/mem.2003.312     Document Type: Letter

References (5)

1. Donaldson L. A communication to all doctors from the Chief Medical Officer, January 2003. UK Department of Health Web site. Available at: http://www. doh.gov.uk/cmo/cmo_35.htm#20.Accessed June 12, 2003.
2. Ho PC, Kwan MS. A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception. Hum Reprod. 1993;8:389-392.
3. Task Force on Postovulatory Methods of Fertility Regulation. Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet. 1998;352:428-433.
4. Von Hertzen H, Piaggio G, Ding J, et al. Low dose mifepristoiie and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet. 2002;360:1803-1810.
5. Harrison-Woolrych M, Woolley J. Progestogenonly emergency contraception and ectopic pregnancy. J Fam Plann Reprod Health Care. 2003;29:5-6.